Oncology Today

Sign up for Oncology Today

In our monthly publication, Oncology Today, we discuss issues relevant to your practice — from prescribing cancer therapeutics to new treatments in the drug pipeline. We distribute Oncology Today to clinicians throughout the U.S. You can access issues below. You can also provide your email address to receive new issues in your inbox.


February 2017: Improving Patient Outcomes Through Customized Clinical Care

To support your practice and patients, we believe it’s becoming increasingly important for specialty pharmacies to play a role in clinical care for oncology patients – driving adherence, providing counseling, and supporting your treatment plans and goals. Many providers are now looking to specialty pharmacies to be an extension of their care team, requiring t… Read More

January 2017: Biologics’ New Specialty Pharmacy Model Meets the Evolving Needs of Oncology Practices

By Dan Duffy, VP/GM, Biologics Oncology Pharmacy, McKesson Specialty Health With many new oral oncolytics recently on the market and many more in the pipeline, ensuring that patients can gain access to promising new therapies is becoming an increasing challenge for oncology practices. In 2015, nine oral cancer drugs were approved by the FDA,1 and… Read More

December 2016 | Tips for Providers: Help Your Patients Navigate Year-end Insurance Challenges

Like you, Biologics is keenly aware of the challenges many patients face around the New Year. New insurance plans, high deductibles and financial assistance needs are just some of the tasks that patients and their care team must navigate, and coordinating all of these aspects of care can be daunting. We’ve summarized the following challenges… Read More

November 2016: Secondary mutation testing for EGFR NSCLC patients after relapse

Many patients relapse after initial treatment for EGFR-positive non-small cell lung cancer (NSCLC). Before continuing the same treatment or trying a second-line therapy, it’s important to test for additional mutations that may have developed during initial treatment. The T790M mutation is the most common mutation of resistance, occurring in 63% of EGFR NSCLC patients who… Read More

October 2016: Medicare Part D 2017 Coverage and Gaps

Medicare’s open enrollment period began on October 15 and will last through December 7. During this time, Medicare beneficiaries have the option to change their prescription drug coverage plan, Medicare Part D, to better meet their healthcare needs. Patients can find Medicare plans by searching www.medicare.gov. The average basic premium for a Medicare Part D… Read More

Simplify the Prior Authorization Process for Oral Oncolytics

Prior authorizations are sometimes required by insurers before a procedure or medication will be covered under the patient’s plan. While the goal of prior authorizations is to promote safe, effective treatment for patients, the process can cost practices valuable time and money. Recent trends in prior authorizations The most common areas where prior authorizations ar… Read More

August 2016: Improving patient adherence to oral oncolytics

Clinical support from your specialty pharmacy Oral oncology medications now make up 38% of the U.S. oncology drug market, up from 23% in 2005i. As more oral oncolytics continue coming to market, specialty pharmacies will continue to become an increasingly important part of your patients’ care team. To help support your patients who are taking… Read More

July 2016 | Oncology Care Model: The Transition to Value-based Care

In a move that payers will undoubtedly watch carefully, the Centers for Medicare and Medicaid Services (CMS) launched a new payment and care delivery model for the treatment of cancer patients on July 1. The Oncology Care Model (OCM) aims to improve care and lower costs by financially incentivizing high-quality, coordinated carei. Through this episode-based… Read More

June 2016: ASCO Recap

New Promise for Patients – Highlights of ASCO 2016 You would expect to hear news of innovation and hope at the world’s largest medical conference focused on cancer research. The annual meeting of the American Society of Clinical Oncology (ASCO) delivered that and more. Under the theme “Collective Wisdom: The future of patient-centered care and… Read More

April 2016: Mobile Health in the Oncology Space

The mobile health (mHealth) movement continues to gain steam in the unpredictable way common to new technology. Today consumers can choose from more than 165,000 health apps on the market, but only 36 apps are responsible for nearly half of all downloads, according to the IMS Institute for Healthcare Informaticsi. The most popular tools promote genera… Read More